US Stock MarketDetailed Quotes

CMMB Chemomab Therapeutics

Watchlist
  • 2.120
  • +0.030+1.44%
Close Jan 23 16:00 ET
39.98MMarket Cap-2.26P/E (TTM)

Chemomab Therapeutics Key Stats

Chemomab Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 14, 20242024/Q30.000 / 0.000--
Aug 21, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 14, 20242024/Q30.000 / 0.000--
Aug 21, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Chemomab Therapeutics Earnings Reports

Read more

Trending Stocks

Discussing
December CPI comes in as expected, is that enough?
U.S. December CPI rose 2.9% year-on-year, aligning with expectations but marking a three-month inflation increase trend. The market reacted Show More